GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | November 21, 2024 |
PDB ID | UniProt ID | Title | Descriptor ▼ |
---|---|---|---|
8VT3 | Q6WB98 | cryo-EM structure of HMPV (MPV-2cREKR) | |
8KAQ | B1W1N0 | Glycoside hydrolase family 1 beta-glucosidase (E318G mutant) from Streptomyces griseus (sophorose complex) | |
8KB7 | Q8NAT1 | Crystal structure of UDP/mannose-bound AGO61/beta-1,4-N-Acetylglucosaminyltransferase 2 (POMGNT2) | |
8PXY | O53223 | Crystal structure of the transpeptidase LdtMt2 C354S mutant from Mycobacterium tuberculosis in complex with natural substrate | |
8PXY | 8PXY | Crystal structure of the transpeptidase LdtMt2 C354S mutant from Mycobacterium tuberculosis in complex with natural substrate | |
8Q1D | P71447 | D10N variant of beta-phosphoglucomutase from Lactococcus lactis in complex with fructose 1,6-bisphosphate | |
8Q1E | A0A0A7T4I1 | D10N,P146A variant of beta-phosphoglucomutase from Lactococcus lactis in complex with fructose 1,6-bisphosphate | |
8Q1F | A0A0A7T4I1 | D10N,P146A variant of beta-phosphoglucomutase from Lactococcus lactis in complex with native beta-glucose 1,6-bisphosphate intermediate | |
8RUR | Q89EJ6 | High pH (8.0) nitrite-bound MSOX movie series dataset 2 of the copper nitrite reductase (NirK) from Bradyrhizobium japonicum USDA110 [1.38 MGy] | |
8SDH | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC25.56 | |
8SDH | 8SDH | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC25.56 | |
8T4Z | P11609 | T-cell receptor and lipid complex structure | |
8T4Z | P01887 | T-cell receptor and lipid complex structure | |
8T4Z | A0A0B4J1J9 | T-cell receptor and lipid complex structure | |
8T4Z | K7N5M3 | T-cell receptor and lipid complex structure | |
8T4Z | A2NTY6 | T-cell receptor and lipid complex structure | |
8T4Z | P0DTU4 | T-cell receptor and lipid complex structure | |
8TNU | 8TNU | Cryo-EM structure of TRNM-b*01 Fab in complex with HIV-1 Env trimer BG505.DS SOSIP | |
8TNU | Q2N0S5 | Cryo-EM structure of TRNM-b*01 Fab in complex with HIV-1 Env trimer BG505.DS SOSIP | |
8TO7 | Q2N0S5 | Cryo-EM structure of HERH-b*01 Fab in complex with HIV-1 Env trimer BG505.DS SOSIP | |
8TO7 | 8TO7 | Cryo-EM structure of HERH-b*01 Fab in complex with HIV-1 Env trimer BG505.DS SOSIP | |
8TO9 | 8TO9 | Cryo-EM structure of TRNM-f*01 Fab in complex with HIV-1 Env trimer ConC SOSIP | |
8TOP | Q2N0S6 | Cryo-EM structure of HIV-1 Env BG505 DS-SOSIP in complex with antibody GPZ6-b.01 targeting the fusion peptide | |
8TOP | 8TOP | Cryo-EM structure of HIV-1 Env BG505 DS-SOSIP in complex with antibody GPZ6-b.01 targeting the fusion peptide | |
8TQ1 | Q2N0S6 | HIV-1 BG505 Env SOSIP in complex with bovine Fab Bess4 and non-human primate Fab RM20A3 | |
8TQ1 | Q2N0S5 | HIV-1 BG505 Env SOSIP in complex with bovine Fab Bess4 and non-human primate Fab RM20A3 | |
8TQ1 | 8TQ1 | HIV-1 BG505 Env SOSIP in complex with bovine Fab Bess4 and non-human primate Fab RM20A3 | |
8VBY | Q01959 | Structure of the human dopamine transporter in complex with beta-CFT, MRS7292 and divalent zinc | |
8VCX | Q30069 | Human TCR A2.13 in complex with DQ8-InsCpep | |
8VCX | O19707 | Human TCR A2.13 in complex with DQ8-InsCpep | |
8VCX | P01308 | Human TCR A2.13 in complex with DQ8-InsCpep | |
8VCX | 8VCX | Human TCR A2.13 in complex with DQ8-InsCpep | |
8VCY | Q30069 | Human TCR A2.13 in complex with DQ8-InsC8-15NPY | |
8VCY | O19707 | Human TCR A2.13 in complex with DQ8-InsC8-15NPY | |
8VCY | 8VCY | Human TCR A2.13 in complex with DQ8-InsC8-15NPY | |
8VD0 | Q30069 | Human TCR ET650-4 in complex with DQ8-InsC8-15-IAPP2 | |
8VD0 | O19707 | Human TCR ET650-4 in complex with DQ8-InsC8-15-IAPP2 | |
8VD0 | 8VD0 | Human TCR ET650-4 in complex with DQ8-InsC8-15-IAPP2 | |
8VD0 | O19707 | Human TCR ET650-4 in complex with DQ8-InsC8-15-IAPP2 | |
8VD0 | 8VD0 | Human TCR ET650-4 in complex with DQ8-InsC8-15-IAPP2 | |
8VD2 | Q30069 | Human TCR ET650-4 in complex with DQ8-InsC8-15-IAPP1 | |
8VD2 | O19707 | Human TCR ET650-4 in complex with DQ8-InsC8-15-IAPP1 | |
8VD2 | 8VD2 | Human TCR ET650-4 in complex with DQ8-InsC8-15-IAPP1 | |
8VDD | Q30069 | Crystal structure of Proinsulin C-peptide bound to HLA-DQ8 | |
8VDD | O19707 | Crystal structure of Proinsulin C-peptide bound to HLA-DQ8 | |
8VDD | P01308 | Crystal structure of Proinsulin C-peptide bound to HLA-DQ8 | |
8VDU | Q30069 | Crystal structure of hybrid insulin peptide (InsC8-15-IAPP74-80) bound to HLA-DQ8 | |
8VDU | O19707 | Crystal structure of hybrid insulin peptide (InsC8-15-IAPP74-80) bound to HLA-DQ8 | |
8VDU | 8VDU | Crystal structure of hybrid insulin peptide (InsC8-15-IAPP74-80) bound to HLA-DQ8 | |
7XYD | O15393 | Crystal structure of TMPRSS2 in complex with Nafamostat |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024